Results
1 -
5 of
5The Discovery and Development of Eg5 Inhibitors for the Clinic, Kinesins and Cancer A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors, Investigational New Drugs I. L. Gonçalves, L. Rockenbach, G. M. das Neves, G. Göethel, F. Nascimento, L. Porto Kagami, et al..
6